- Telehealth Visits
- Insurance plan information
Noriko Tei Boyd Anderson, MD, MPH
Neurology- Telehealth Visits
- Insurance plan information
Noriko Tei Boyd Anderson, MD, MPH
Neurology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Noriko Tei Boyd Anderson is a neurologist with a particular interest in caring for patients with brachial neuritis, a disorder affecting the nerves around the shoulder and arm.
Anderson earned her medical degree from UCSF. She completed a residency in neurology at the University of California, Irvine, followed by a neuromuscular fellowship at UCSF. She also has a master of public health degree from the University of California, Los Angeles.
Education & training
Board certification
- Neuromuscular Medicine, American Board of Psychiatry and Neurology
- Neurology, American Board of Psychiatry/Neurology-Neurology
Fellowship
- Neuromuscular Medicine, UCSF Graduate Medical Education
Residency
- Neurology, University of California - Irvine Medical Center
Internship
- Internal Medicine, Alameda Health System - Highland Hospital
Degree
- MD, UCSF School of Medicine
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 37 reviews
- February 25, 20265 out of 5 Stars
I am very lucky to have found such an awesome person
- February 7, 20265 out of 5 Stars
Very helpful
- February 7, 20265 out of 5 Stars
Dr Anderson listens closely and provides thoughtful and compassionate care.
- February 7, 20265 out of 5 Stars
Outstanding provider.
- January 23, 20264.1 out of 5 Stars
I just want feedback regarding all my tests my caregiver prescribed.
- January 19, 20265 out of 5 Stars
I was moved that she said that if she'd seen my message refusing the PA appointment that she would have seen me sooner.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.